Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  815 نتائج ل ""Drug Resistance, Neoplasm""

فلترة النتائج

Subject : paclitaxel
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Transcriptomic Landscape of Paclitaxel-Induced Multidrug Resistance in 3D Cultures of Colon Cancer Cell Line DLD1.

  • Authors : Dragicevic S; Gene Regulation in Cancer Group, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia.; Dinic J

Subjects: Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/genetics ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/pathology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jul 09; Vol. 26 (14). Date of Electronic Publication: 2025 Jul 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m 6 A methylation of TNFSF9 and inducing polarization of tumor-associated macrophages to M2 phenotype.

  • Authors : Fu J; Department of General Surgery, Xianyang Hospital of Yan'an University, Xianyang, Shaanxi, China.; Wei C

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology

  • Source: Hereditas [Hereditas] 2025 Aug 19; Vol. 162 (1), pp. 167. Date of Electronic Publication: 2025 Aug 19.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 0374654 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance.

  • Authors : Schirizzi A; National Institute of Gastroenterology, IRCCS 'Saverio de Bellis' Research Hospital, Castellana Grotte, BA, 70013, Italy.; Renna N

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/metabolism

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Jul 16; Vol. 44 (1), pp. 209. Date of Electronic Publication: 2025 Jul 16.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mechanisms and Therapeutic Strategies for Minority Cell-Induced Paclitaxel Resistance and Tumor Progression Mediated by Mechanical Forces.

  • Authors : Feng X; State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Institute of Chemistry, CAS Research/Education Center for Excellence in Molecular Sciences, Chinese Academy of Science, Beijing, 100190, P. R. China.; University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 Jun; Vol. 12 (22), pp. e2417805. Date of Electronic Publication: 2025 Apr 24.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer.

  • Authors : Ge Y; Department of Biochemistry and Molecular Biology, Health Science Center, Ningbo University, Ningbo, Zhejiang, China.; Kong L

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy

  • Source: Communications biology [Commun Biol] 2025 Apr 17; Vol. 8 (1), pp. 624. Date of Electronic Publication: 2025 Apr 17.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic-nuclear shuttling in human triple-negative breast cancer.

  • Authors : Huang S; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Paclitaxel*/Paclitaxel*/Paclitaxel*/therapeutic use ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy

  • Source: Clinical and translational medicine [Clin Transl Med] 2025 Feb; Vol. 15 (2), pp. e70203.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Predicting tumour resistance to paclitaxel and carboplatin utilising genome-wide screening in haploid human embryonic stem cells.

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Carboplatin*/Carboplatin*/Carboplatin*/pharmacology ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics

  • Source: Cell proliferation [Cell Prolif] 2025 Mar; Vol. 58 (3), pp. e13771. Date of Electronic Publication: 2024 Nov 10.Publisher: Published for the Cell Kinetics Society, the European Study Group for Cell Proliferation, and the International Cell Cycle Society by Blackwell Scientific Publications

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms.

  • Authors : Calistri NL; Biomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.; Liby TA

Subjects: Paclitaxel*/Paclitaxel*/Paclitaxel*/pharmacology ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics

  • Source: Scientific reports [Sci Rep] 2025 Feb 04; Vol. 15 (1), pp. 4294. Date of Electronic Publication: 2025 Feb 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models.

  • Authors : Stasiak P; Institute of Biological Sciences, University of Zielona Góra, 65-417 Zielona Góra, Poland.; The Doctoral School of Exact and Technical Sciences, University of Zielona Góra, 65-417 Zielona Góra, Poland.

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/metabolism ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jan 28; Vol. 26 (3). Date of Electronic Publication: 2025 Jan 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Chemotherapeutic hormesis induced by the tumor microenvironment in refractory ovarian cancer.

  • Authors : Chang X; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan.; Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, 518036, China.

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/metabolism

  • Source: Scientific reports [Sci Rep] 2025 Jan 02; Vol. 15 (1), pp. 596. Date of Electronic Publication: 2025 Jan 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  815 نتائج ل ""Drug Resistance, Neoplasm""